PATENT CLAIM ANALYSIS

Application Number: 15978064
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
The present invention concerns methods for treating progressive multiple sclerosis (MS) in a patient, and an article of manufacture with instructions for such use.

Claim (Index 1):
A method of treating progressive multiple sclerosis in a patient comprising administering to the patient an effective amount of an anti-CD20 antibody, wherein treatment is based upon the patient having one or more characteristics selected from the group consisting of (a) an age less than about 55 years, (b) one or more gadolinium staining lesions, (c) at least about a one point increase in Expanded Disability Status Scale (EDSS) over two years prior to starting treatment, and (d) a Multiple Sclerosis Severity Score (MSSS) greater than about 5 points.

Metadata:
- Claim Count in Document: 129.0
- Percentile: 93.0
- Lexical Diversity: 1.03704
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15597021', '15201300', '11437296', '12256349', '15019615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7178454118950757
- 35 USC 102 Novelty (BERT): 0.5926502089617345
- Combined Prediction Score: 0.7053258916017416
- Mean Citation Score: 379.353092
- Max Citation Score: 566.5535
- Similarity Product: 406.195360445261

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test